[Immunotherapy of postoperative cancer patients with immune RNA-sensitized lymphocytes and tumor antigen]. 1983

M Fukushima, and K Takashima, and M Sato, and M Yamauchi, and M Tachibana, and T Kawaguchi, and H Koie

Tumor cell suspension was prepared from resected tumor tissue of various cancer patients. 1-RNA was extracted from lymphoid tissues of rabbits immunized with each tumor cells and CFA. When the postoperative condition of patient recovered stable, autologous lymphocytes were prepared with blood cell separator (IBM 2997 type) and incubated with I-RNA, then, return to himself. Total number of sensitized lymphocytes was 4 X 10(9) - 1.2 X 10(10). After this passive immunization was finished, active immunization with autologous 3M KCl tumor extract was added. Three of gastrointestinal cancer, 3 of lung cancer, 2 of miscellaneous malignant tumor were treated with this schedule. T-cell ratio, blastogenesis of T-cell with PHA, skin reaction with PPD and PHA, CEA, IAP and Ig in serum was not definitely changed before and after the immunotherapy. But 3 of them, LAI AND LMI became to positive after the treatment and NK cell activity also increased in 3 cases. In these 3 cases, tumor regression was recognized after the treatment. In a case of synovial sarcoma, skin reaction for autologous tumor antigen became to positive and the metastatic lesion in the lung was gradually regressed and regression is still continuing 6 months after the treatment (reduction ratio 90%).

UI MeSH Term Description Entries
D007116 Immunization, Passive Transfer of immunity from immunized to non-immune host by administration of serum antibodies, or transplantation of lymphocytes (ADOPTIVE TRANSFER). Convalescent Plasma Therapy,Immunoglobulin Therapy,Immunotherapy, Passive,Normal Serum Globulin Therapy,Passive Antibody Transfer,Passive Transfer of Immunity,Serotherapy,Passive Immunotherapy,Therapy, Immunoglobulin,Antibody Transfer, Passive,Passive Immunization,Therapy, Convalescent Plasma,Transfer, Passive Antibody
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011184 Postoperative Period The period following a surgical operation. Period, Postoperative,Periods, Postoperative,Postoperative Periods
D003110 Colonic Neoplasms Tumors or cancer of the COLON. Cancer of Colon,Colon Adenocarcinoma,Colon Cancer,Cancer of the Colon,Colon Neoplasms,Colonic Cancer,Neoplasms, Colonic,Adenocarcinoma, Colon,Adenocarcinomas, Colon,Cancer, Colon,Cancer, Colonic,Cancers, Colon,Cancers, Colonic,Colon Adenocarcinomas,Colon Cancers,Colon Neoplasm,Colonic Cancers,Colonic Neoplasm,Neoplasm, Colon,Neoplasm, Colonic,Neoplasms, Colon
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

M Fukushima, and K Takashima, and M Sato, and M Yamauchi, and M Tachibana, and T Kawaguchi, and H Koie
April 1979, Neurologia medico-chirurgica,
M Fukushima, and K Takashima, and M Sato, and M Yamauchi, and M Tachibana, and T Kawaguchi, and H Koie
January 1979, Cellular and molecular biology, including cyto-enzymology,
M Fukushima, and K Takashima, and M Sato, and M Yamauchi, and M Tachibana, and T Kawaguchi, and H Koie
January 1982, International journal of cancer,
M Fukushima, and K Takashima, and M Sato, and M Yamauchi, and M Tachibana, and T Kawaguchi, and H Koie
January 1992, Cancer investigation,
M Fukushima, and K Takashima, and M Sato, and M Yamauchi, and M Tachibana, and T Kawaguchi, and H Koie
February 1997, Chinese medical journal,
M Fukushima, and K Takashima, and M Sato, and M Yamauchi, and M Tachibana, and T Kawaguchi, and H Koie
April 2004, Zhongguo shi yan xue ye xue za zhi,
M Fukushima, and K Takashima, and M Sato, and M Yamauchi, and M Tachibana, and T Kawaguchi, and H Koie
January 1976, Annals of the New York Academy of Sciences,
M Fukushima, and K Takashima, and M Sato, and M Yamauchi, and M Tachibana, and T Kawaguchi, and H Koie
April 1997, Neurological research,
M Fukushima, and K Takashima, and M Sato, and M Yamauchi, and M Tachibana, and T Kawaguchi, and H Koie
December 1974, Seminars in oncology,
M Fukushima, and K Takashima, and M Sato, and M Yamauchi, and M Tachibana, and T Kawaguchi, and H Koie
November 1995, Gan to kagaku ryoho. Cancer & chemotherapy,
Copied contents to your clipboard!